The Research on the Treatment of Metastatic Skin Cutaneous Melanoma by Huanglian Jiedu Decoction Based on the Analysis of Immune Infiltration Analysis

Figure 9

The prognostic value of core genes and immune cells in METASTATIC CM (TIMER). (a) METASTATIC CM patients with low expression of CXCL12 have a poor prognosis ( value = 0.12). (b) METASTATIC CM patients with low expression of CXCL9 have a poor prognosis ( value = 0). (c) METASTATIC CM patients with low expression of CCL21 have a poor prognosis ( value = 0.807). (d) METASTATIC CM patients with high expression of C3 have a poor prognosis ( value = 0.062). (e) METASTATIC CM patients with low expression of CXCL13 have a poor prognosis ( value = 0). (f) METASTATIC CM patients with high expression of APP have a poor prognosis ( value = 0.513). (g) METASTATIC CM patients with low expression of CCL19 have a poor prognosis ( value = 0.168). (h) METASTATIC CM patients with low expression of C3AR1 have a poor prognosis ( value = 0). (i) METASTATIC CM patients with high expression of CCL27 have a poor prognosis ( value = 0.813). (j) METASTATIC CM patients with low expression of GAL have a poor prognosis ( value = 0.001). Low-abundance B cells ( value = 0.001), CD8 + cells ( value = 0), macrophage ( value = 0.353), neutrophils ( value = 0) and dendritic cells ( value = 0) and high-abundance CD4+T cell ( value = 0.875) have a poor prognosis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)